erlotinib has been researched along with sb 220025 in 3 studies
Studies (erlotinib) | Trials (erlotinib) | Recent Studies (post-2010) (erlotinib) | Studies (sb 220025) | Trials (sb 220025) | Recent Studies (post-2010) (sb 220025) |
---|---|---|---|---|---|
221 | 0 | 180 | 29 | 0 | 7 |
Protein | Taxonomy | erlotinib (IC50) | sb 220025 (IC50) |
---|---|---|---|
Chain A, MAP KINASE P38 | Homo sapiens (human) | 9.0095 | |
Chain A, PROTEIN (MAP KINASE P38) | Homo sapiens (human) | 9.0095 | |
Chain A, PROTEIN (MAP KINASE P38) | Homo sapiens (human) | 9.0095 | |
Chain A, Protein (map Kinase P38) | Homo sapiens (human) | 9.0095 | |
Chain A, Extracellular Regulated Kinase 2 | Rattus norvegicus (Norway rat) | 9.0095 | |
Chain A, Extracellular Regulated Kinase 2 | Rattus norvegicus (Norway rat) | 9.0095 | |
Mitogen-activated protein kinase 13 | Homo sapiens (human) | 0.019 | |
Mitogen-activated protein kinase 12 | Homo sapiens (human) | 0.019 | |
Mitogen-activated protein kinase 1 | Rattus norvegicus (Norway rat) | 0.019 | |
Mitogen-activated protein kinase 11 | Homo sapiens (human) | 0.019 | |
Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.0193 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB | 1 |
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
3 other study(ies) available for erlotinib and sb 220025
Article | Year |
---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
Navigating the kinome.
Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology | 2011 |
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |